Rational and irrational issues in breast cancer screening

Area of Science:

• Oncology
• Public Health
• Evidence-Based Medicine

Background:

• Decades of randomized controlled trials (RCTs) on breast screening efficacy have yielded controversial results regarding mortality reduction.
• Recent assessments suggest potential benefits may be smaller than previously anticipated, alongside concerns of over-diagnosis and overtreatment.

Purpose of the Study:

• To review evidence on breast screening efficacy from late 20th-century RCTs.
• To address controversies surrounding the magnitude of mortality reduction and the impact of screening consequences.
• To examine the influence of vested interests on health policy related to breast screening guidelines.

Main Methods:

• Review of randomized controlled trials on breast screening conducted in the late 1900s.
• Analysis of critiques and responses to screening trial results and expert guidelines.
• Discussion of the role of vested interests in health policy formulation.

Main Results:

• Evidence suggests breast screening benefits, specifically mortality reduction, may be less substantial than initially claimed.
• Critiques of certain trials, such as the Canadian National Breast Screening Study, are contested.
• The response to the United States Preventive Services Task Force 2009 guidelines illustrates the influence of vested interests and resistance to new paradigms.

Conclusions:

• The actual mortality reduction from breast screening requires careful re-evaluation.
• Over-diagnosis and overtreatment are significant concerns associated with breast screening programs.
• Understanding the influence of vested interests is crucial for objective health policy decisions regarding screening.